Skip to main content
Home
Knowledge Base
for the National TB Elimination Program - NTEP

Main navigation

  • Home
    • About Us
  • Curriculum
    • Search Courses
  • Knowledge Map
    • Knowledge Map Summary
  • Page Library
    • Content Page Summary
    • Translations
  • Documents

Search

Page Prioritised

  1. Home
  2. Page Prioritised

Default status of page at the time it is added for creation.

Aims and Objectives of Screening for Active TB

H5Content

Baseline Second-line Drug-susceptibility Testing

H5Content

Newer Anti-TB Drugs: Delamanid [Dlm]

H5Content

Delamanid [Dlm] Drug Dosages and Duration​

H5Content

Use of Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen in Pre-existing Liver Disease

Stakeholders for Private Sector Engagement

H5Content

Managerial Skills

CBNAAT Xpert MTB/RIF - Indications of use under NTEP

Norms and requirements of a DMC

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Page 24
Subscribe to Page Prioritised

User account menu

  • Log in

This work is licensed under Attribution-NonCommercial 4.0 International